Cargando…

A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial

BACKGROUND: Women with breast cancer undergoing chemotherapy suffer from a number of symptoms and report receiving inadequate support from health care professionals. Innovative and easily accessible interventions are lacking. Breast Cancer e-Support is a mobile Application program (App) that provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jiemin, Ebert, Lyn, Liu, Xiangyu, Chan, Sally Wai-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406970/
https://www.ncbi.nlm.nih.gov/pubmed/28446141
http://dx.doi.org/10.1186/s12885-017-3276-7
_version_ 1783232071473299456
author Zhu, Jiemin
Ebert, Lyn
Liu, Xiangyu
Chan, Sally Wai-Chi
author_facet Zhu, Jiemin
Ebert, Lyn
Liu, Xiangyu
Chan, Sally Wai-Chi
author_sort Zhu, Jiemin
collection PubMed
description BACKGROUND: Women with breast cancer undergoing chemotherapy suffer from a number of symptoms and report receiving inadequate support from health care professionals. Innovative and easily accessible interventions are lacking. Breast Cancer e-Support is a mobile Application program (App) that provides patients with individually tailored information and a support group of peers and health care professionals. Breast Cancer e-Support aims to promote women’s self-efficacy, social support and symptom management, thus improving their quality of life and psychological well-being. METHODS: A single-blinded, multi-centre, randomised, 6-month, parallel-group superiority design will be used. Based on Bandura’s self-efficacy theory and the social exchange theory, Breast Cancer e-Support has four modules: 1) a Learning forum; 2) a Discussion forum; 3) an Ask-the-Expert forum; and 4) a Personal Stories forum. Women with breast cancer (n = 108) who are commencing chemotherapy will be recruited from two university-affiliated hospitals in China. They will be randomly assigned to either control group that receives routine care or intervention group that receives routine care plus access to Breast Cancer e-Support program during their four cycles of chemotherapy. Self-efficacy, social support, symptom distress, quality of life, and anxiety and depression will be measured at baseline, then one week and 12 weeks post-intervention. DISCUSSION: This is the first study of its kind in China to evaluate the use of a mobile application intervention with a rigorous research design and theoretical framework. This study will contribute to evidence regarding the effectiveness of a theory-based mobile application to support women with breast cancer undergoing chemotherapy. The results should provide a better understanding of the role of self-efficacy and social support in reducing symptom distress and of the credibility of using a theoretical framework to develop internet-based interventions. The results will provide evidence to support the implementation of an innovative and easily accessible intervention that enhances health outcomes. TRIAL REGISTRATION: ACTRN: ACTRN12616000639426, Registered 17 May, 2016. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3276-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5406970
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54069702017-04-27 A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial Zhu, Jiemin Ebert, Lyn Liu, Xiangyu Chan, Sally Wai-Chi BMC Cancer Study Protocol BACKGROUND: Women with breast cancer undergoing chemotherapy suffer from a number of symptoms and report receiving inadequate support from health care professionals. Innovative and easily accessible interventions are lacking. Breast Cancer e-Support is a mobile Application program (App) that provides patients with individually tailored information and a support group of peers and health care professionals. Breast Cancer e-Support aims to promote women’s self-efficacy, social support and symptom management, thus improving their quality of life and psychological well-being. METHODS: A single-blinded, multi-centre, randomised, 6-month, parallel-group superiority design will be used. Based on Bandura’s self-efficacy theory and the social exchange theory, Breast Cancer e-Support has four modules: 1) a Learning forum; 2) a Discussion forum; 3) an Ask-the-Expert forum; and 4) a Personal Stories forum. Women with breast cancer (n = 108) who are commencing chemotherapy will be recruited from two university-affiliated hospitals in China. They will be randomly assigned to either control group that receives routine care or intervention group that receives routine care plus access to Breast Cancer e-Support program during their four cycles of chemotherapy. Self-efficacy, social support, symptom distress, quality of life, and anxiety and depression will be measured at baseline, then one week and 12 weeks post-intervention. DISCUSSION: This is the first study of its kind in China to evaluate the use of a mobile application intervention with a rigorous research design and theoretical framework. This study will contribute to evidence regarding the effectiveness of a theory-based mobile application to support women with breast cancer undergoing chemotherapy. The results should provide a better understanding of the role of self-efficacy and social support in reducing symptom distress and of the credibility of using a theoretical framework to develop internet-based interventions. The results will provide evidence to support the implementation of an innovative and easily accessible intervention that enhances health outcomes. TRIAL REGISTRATION: ACTRN: ACTRN12616000639426, Registered 17 May, 2016. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3276-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-26 /pmc/articles/PMC5406970/ /pubmed/28446141 http://dx.doi.org/10.1186/s12885-017-3276-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Zhu, Jiemin
Ebert, Lyn
Liu, Xiangyu
Chan, Sally Wai-Chi
A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial
title A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial
title_full A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial
title_fullStr A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial
title_full_unstemmed A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial
title_short A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial
title_sort mobile application of breast cancer e-support program versus routine care in the treatment of chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406970/
https://www.ncbi.nlm.nih.gov/pubmed/28446141
http://dx.doi.org/10.1186/s12885-017-3276-7
work_keys_str_mv AT zhujiemin amobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial
AT ebertlyn amobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial
AT liuxiangyu amobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial
AT chansallywaichi amobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial
AT zhujiemin mobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial
AT ebertlyn mobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial
AT liuxiangyu mobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial
AT chansallywaichi mobileapplicationofbreastcanceresupportprogramversusroutinecareinthetreatmentofchinesewomenwithbreastcancerundergoingchemotherapystudyprotocolforarandomizedcontrolledtrial